uploads/2018/05/teeth-1652937_1280.jpg

Align Technology: Analysts Raise Their Target Prices

By

Updated

Align Technology stock

On May 25, Berenberg increased its 12-month target price on Align Technology (ALGN) from $312 to $340. Yesterday, Leerink and Jefferies raised their target prices for the stock from $305 to $360 and $300 to $350, respectively. The company increased its long-term revenue growth rate target range from 15%–25% to 20%–30% during its investor day on May 23. Align Technology reaffirmed its second quarter and fiscal 2018 guidance.

Article continues below advertisement

In a report released on May 22, Stifel Nicolaus raised its target price for Align Technology from $320 to $350. The firm maintained its “buy” rating on Align Technology stock. The increased target price represents a potential investment return of ~15.7% on an investment in Align Technology for the next 12 months. Stifel Nicolaus increased its target price on Align Technology for the third time since the beginning of 2018.

Consensus recommendations

Let’s take a look at analysts’ consensus recommendations on Align Technology for the next 12 months. As of May 23, according to a Reuters survey comprised of 15 brokerages covering Align Technology stock, 80% or 12 of the analysts gave Align Technology “buy” or “strong buy” recommendations, while 20% or three analysts gave “hold” recommendations on the stock. None of the analysts gave a “sell” recommendation.

Target price

As of May 23, analysts’ consensus 12-month target price for Align Technology is 324.1, which implies an upside potential of ~2.2% over an investment in the stock for the next 12 months. The return is based on Align Technology’s closing price of $317 on May 24.

Dentsply Sirona (XRAY), Zimmer Biomet Holdings (ZBH), and Danaher (DHR) have average broker target prices of $59.4, $132.6, and $111.4, respectively. These figures imply returns of 28.5%, 18.7%, and 8.9%, respectively, over the next 12 months.

Check out all the data we’ve added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data as well as dividend info. Take a look!

Advertisement

More From Market Realist